Perrigo Company plc (NYSE:PRGO) Stock Rated “Hold” by Sell-Side Analysts

Shares of Perrigo Company plc (NYSE:PRGO) have been assigned an average rating of “Hold” from the six analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $19.33.

A number of equities analysts recently issued reports on the company. Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. Wall Street Zen downgraded Perrigo from a “strong-buy” rating to a “buy” rating in a report on Sunday, September 27th.

Institutional Trading of Perrigo

Hedge funds have recently bought and sold shares of the company. Bank of America Corp DE grew its holdings in shares of Perrigo by 25.5% during the 1st quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock valued at $16,847,000 after acquiring an additional 318,248 shares in the last quarter. Gamco Investors INC. ET AL raised its holdings in shares of Perrigo by 29.7% during the first quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock worth $15,013,000 after acquiring an additional 320,081 shares in the last quarter. Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in shares of Perrigo during the second quarter worth $4,066,000. Empowered Funds LLC boosted its position in Perrigo by 41.6% during the first quarter. Empowered Funds LLC now owns 511,872 shares of the company’s stock valued at $5,498,000 after purchasing an additional 150,438 shares during the last quarter. Finally, Gabelli Funds LLC boosted its position in Perrigo by 29.8% during the first quarter. Gabelli Funds LLC now owns 893,359 shares of the company’s stock valued at $9,595,000 after purchasing an additional 205,311 shares during the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Price Performance

PRGO stock traded down $0.06 on Tuesday, hitting $15.39. 163,195 shares of the company’s stock traded hands, compared to its average volume of 3,072,874. The stock has a market cap of $2.14 billion, a price-to-earnings ratio of -1.23, a P/E/G ratio of 1.72 and a beta of 0.69. Perrigo has a 1-year low of $9.23 and a 1-year high of $22.02. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31. The stock has a fifty day moving average of $13.97 and a 200-day moving average of $11.90.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.11. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, analysts forecast that Perrigo will post 2.18 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 7.5%. The ex-dividend date was Friday, August 28th. Perrigo’s payout ratio is presently -9.27%.

Perrigo Company Profile

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products.